1,2-dimethylhydrazine increases expression ISO RGD:735980 6480464 1, 2-Dimethylhydrazine results in increased expression of CSNK1D mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733311 6480464 Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CSNK1D mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735980 6480464 Tetrachlorodibenzodioxin affects the expression of CSNK1D mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733311 6480464 Tetrachlorodibenzodioxin results in decreased expression of CSNK1D mRNA CTD PMID:11007951 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CSNK1D mRNA CTD PMID:21346803 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of CSNK1D mRNA CTD PMID:19643169 2-hydroxypropanoic acid increases expression ISO RGD:733311 6480464 Lactic Acid results in increased expression of CSNK1D mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of CSNK1D mRNA CTD PMID:19643169 3,4-methylenedioxymethamphetamine increases expression ISO RGD:735980 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CSNK1D mRNA CTD PMID:20188158 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CSNK1D mRNA CTD PMID:30047161 acrylamide increases expression ISO RGD:733311 6480464 Acrylamide results in increased expression of CSNK1D mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:733311 6480464 Aflatoxin B1 results in decreased methylation of CSNK1D intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:733311 6480464 Tretinoin results in increased expression of CSNK1D mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of CSNK1D mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CSNK1D mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one decreases activity ISO RGD:733311 6480464 pyrazolanthrone results in decreased activity of CSNK1D protein CTD PMID:12534346 antimycin A decreases expression ISO RGD:733311 6480464 Antimycin A results in decreased expression of CSNK1D mRNA CTD PMID:33512557 antirheumatic drug affects expression ISO RGD:733311 6480464 Antirheumatic Agents affects the expression of CSNK1D mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:735980 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CSNK1D mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:733311 6480464 Arsenic affects the methylation of CSNK1D gene CTD PMID:25304211 , PMID:32603190 arsenic atom affects methylation ISO RGD:733311 6480464 Arsenic affects the methylation of CSNK1D gene CTD PMID:25304211 , PMID:32603190 arsenite(3-) increases expression ISO RGD:735980 6480464 arsenite results in increased expression of CSNK1D mRNA CTD PMID:18191166 arsenous acid increases expression ISO RGD:733311 6480464 Arsenic Trioxide results in increased expression of CSNK1D mRNA CTD PMID:20458559 atrazine increases expression ISO RGD:733311 6480464 Atrazine results in increased expression of CSNK1D mRNA CTD PMID:22378314 benzo[a]pyrene increases methylation ISO RGD:733311 6480464 Benzo(a)pyrene results in increased methylation of CSNK1D 3' UTR, Benzo(a)pyrene results in increased methylation of CSNK1D promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733311 6480464 7 more ... CTD PMID:19150397 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CSNK1D mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:733311 6480464 bisphenol A results in decreased methylation of CSNK1D gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:733311 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CSNK1D gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:733311 6480464 bisphenol A results in increased expression of CSNK1D protein CTD PMID:33376534 bisphenol A increases expression ISO RGD:735980 6480464 bisphenol A results in increased expression of CSNK1D mRNA CTD PMID:33221593 bisphenol A decreases expression ISO RGD:733311 6480464 bisphenol A results in decreased expression of CSNK1D mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CSNK1D mRNA CTD PMID:30816183 , PMID:34947998 caffeine affects phosphorylation ISO RGD:733311 6480464 Caffeine affects the phosphorylation of CSNK1D protein CTD PMID:35688186 chlorpyrifos increases expression ISO RGD:735980 6480464 Chlorpyrifos results in increased expression of CSNK1D mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:735980 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSNK1D gene CTD PMID:20938992 clofibrate affects expression ISO RGD:735980 6480464 Clofibrate affects the expression of CSNK1D mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:735980 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CSNK1D mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CSNK1D mRNA] CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:733311 6480464 cobaltous chloride results in increased expression of CSNK1D mRNA CTD PMID:19376846 coumarin increases phosphorylation ISO RGD:733311 6480464 coumarin results in increased phosphorylation of CSNK1D protein CTD PMID:35688186 cycloheximide multiple interactions ISO RGD:733311 6480464 Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CSNK1D mRNA] CTD PMID:11007951 cyclosporin A increases expression ISO RGD:733311 6480464 Cyclosporine results in increased expression of CSNK1D mRNA CTD PMID:20106945 , PMID:25562108 cytarabine decreases expression ISO RGD:733311 6480464 Cytarabine results in decreased expression of CSNK1D mRNA CTD PMID:21198554 diarsenic trioxide increases expression ISO RGD:733311 6480464 Arsenic Trioxide results in increased expression of CSNK1D mRNA CTD PMID:20458559 diazinon affects expression EXP 6480464 Diazinon affects the expression of CSNK1D mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of CSNK1D mRNA CTD PMID:22546817 dioxygen increases expression ISO RGD:735980 6480464 Oxygen deficiency results in increased expression of CSNK1D mRNA CTD PMID:20880076 dorsomorphin multiple interactions ISO RGD:733311 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1D mRNA CTD PMID:27188386 folic acid multiple interactions ISO RGD:735980 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSNK1D gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:733311 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CSNK1D gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of CSNK1D gene CTD PMID:22079235 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CSNK1D mRNA CTD PMID:22061828 , PMID:33387578 hydrogen peroxide decreases secretion ISO RGD:735980 6480464 Hydrogen Peroxide results in decreased secretion of CSNK1D mRNA CTD PMID:21179422 ivermectin decreases expression ISO RGD:733311 6480464 Ivermectin results in decreased expression of CSNK1D protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:735980 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSNK1D gene CTD PMID:20938992 methylmercury chloride increases expression ISO RGD:733311 6480464 methylmercuric chloride results in increased expression of CSNK1D mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:733311 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1D mRNA CTD PMID:27188386 N-methyl-4-phenylpyridinium affects expression ISO RGD:733311 6480464 1-Methyl-4-phenylpyridinium affects the expression of CSNK1D mRNA CTD PMID:12710931 N-methylformamide affects expression ISO RGD:735980 6480464 methylformamide affects the expression of CSNK1D mRNA, methylformamide analog affects the expression of CSNK1D mRNA CTD PMID:17040096 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK1D mRNA CTD PMID:22037397 nickel atom increases expression ISO RGD:733311 6480464 Nickel results in increased expression of CSNK1D mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride decreases expression ISO RGD:733311 6480464 nickel chloride results in decreased expression of CSNK1D mRNA CTD PMID:17312168 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CSNK1D mRNA CTD PMID:22546817 paracetamol multiple interactions ISO RGD:735980 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CSNK1D mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CSNK1D mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:733311 6480464 Acetaminophen results in increased expression of CSNK1D mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:733311 6480464 Acetaminophen results in decreased expression of CSNK1D mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:735980 6480464 Acetaminophen affects the expression of CSNK1D mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735980 6480464 Acetaminophen results in increased expression of CSNK1D mRNA CTD PMID:17585979 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CSNK1D mRNA CTD PMID:22037397 pyrazoles decreases activity ISO RGD:733311 6480464 Pyrazoles analog results in decreased activity of CSNK1D protein CTD PMID:12534346 pyrimidines decreases activity ISO RGD:733311 6480464 Pyrimidines analog results in decreased activity of CSNK1D protein CTD PMID:12534346 rac-lactic acid increases expression ISO RGD:733311 6480464 Lactic Acid results in increased expression of CSNK1D mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:733311 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1D mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:733311 6480464 sodium arsenite results in increased expression of CSNK1D mRNA CTD PMID:22714537 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CSNK1D mRNA CTD PMID:30047161 sunitinib increases expression ISO RGD:733311 6480464 Sunitinib results in increased expression of CSNK1D mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:733311 6480464 Temozolomide results in increased expression of CSNK1D mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:733311 6480464 tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA CTD PMID:15336504 titanium dioxide increases expression ISO RGD:735980 6480464 titanium dioxide results in increased expression of CSNK1D mRNA CTD PMID:27760801 trichostatin A affects expression ISO RGD:733311 6480464 trichostatin A affects the expression of CSNK1D mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:735980 6480464 trimellitic anhydride results in increased expression of CSNK1D mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CSNK1D mRNA CTD PMID:30589522 tunicamycin increases expression ISO RGD:735980 6480464 Tunicamycin results in increased expression of CSNK1D mRNA CTD PMID:17127020 urethane increases expression ISO RGD:733311 6480464 Urethane results in increased expression of CSNK1D mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of CSNK1D mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:735980 6480464 Valproic Acid affects the expression of CSNK1D mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:733311 6480464 Valproic Acid results in increased methylation of CSNK1D gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733311 6480464 Valproic Acid affects the expression of CSNK1D mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:735980 6480464 Valproic Acid results in decreased expression of CSNK1D mRNA CTD PMID:20546886 , PMID:21427059 vanadyl sulfate increases expression ISO RGD:733311 6480464 vanadyl sulfate results in increased expression of CSNK1D mRNA CTD PMID:16330358 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CSNK1D mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CSNK1D mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:733311 6480464 Vitamin E results in decreased expression of CSNK1D mRNA CTD PMID:19244175 zinc atom multiple interactions ISO RGD:733311 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CSNK1D mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:733311 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CSNK1D mRNA CTD PMID:18593933